Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.
about
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesOverlapping and non-overlapping functions of condensins I and II in neural stem cell divisions.Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.Conditional mutation of Smc5 in mouse embryonic stem cells perturbs condensin localization and mitotic progressionSGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells.The abrogation of condensin function provides independent evidence for defining the self-renewing population of pluripotent stem cells.The functional role for condensin in the regulation of chromosomal organization during the cell cycle.The loading of condensin in the context of chromatin.Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.Targeting condensin, a vital spot of MYCN-amplified neuroblastoma.Dangerous liaisons: MYCN meets condensins.Condensins are Required for Maintenance of Nuclear Architecture.Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.Subunits of human condensins are potential therapeutic targets for cancers.Condensin controls cellular RNA levels through the accurate segregation of chromosomes instead of directly regulating transcription
P2860
Q28388497-3358A5AE-93D3-440C-8108-0087E3F0AE31Q34634010-70A8602D-683D-4596-B216-30001E805243Q35223869-097564FF-47CE-43AB-871D-34EF16E8A14BQ36856933-9EC285E3-23D8-46D0-882D-FC1F9C13D567Q37188977-1C96CBC1-3126-4E99-8224-2070DE5C9075Q38652947-6FFD6C93-1EFE-4E4B-804D-B0CF8DE6821DQ38893228-DBB9A830-1DC3-47B3-87C9-55049ED26366Q39026613-CD9912E3-FCFF-4B58-9776-8BAC0769170FQ39756300-01F67B3C-8B80-4F9B-89B5-89B246917429Q40458950-95A1B167-557D-4BF5-9072-3C3123BA58FEQ40458983-EE155198-D99C-4686-ACD0-E80880214851Q42152182-3CCCC010-4BBE-496F-8A34-A6000E659B18Q47136770-BAC477B7-142E-470D-9FF6-2A431DB70768Q52691403-E6C577A2-F009-4907-85A9-8A6FFCEB1D08Q58715129-DA4A4CDB-E63D-4404-A62A-B5172B36DDBE
P2860
Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@ast
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@en
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@nl
type
label
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@ast
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@en
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@nl
prefLabel
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@ast
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@en
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Inactivation of SMC2 shows a s ...... amplified neuroblastoma cells.
@en
P2093
Hiroshi Murakami
Hitoshi Ichikawa
Ichiro Takeuchi
John M Maris
Kenji Kadomatsu
Satoshi Kishida
Yoshitaka Sekido
Yuki Katou
Yuko Murakami-Tonami
Yutaka Kondo
P2860
P304
P356
10.4161/CC.27983
P577
2014-02-07T00:00:00Z